Blood clots after central line removal in ICU
Part of Heart & circulation clinical trials.
This study looks at whether removing a central line (a tube in a large vein) in the ICU increases the risk of blood clots. It may help doctors understand how to prevent clots in ICU patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were in the intensive care unit (ICU) and had a central line placed during your stay.
- Your central line was removed while you were still in the ICU.
- You did not receive full-dose blood-thinning medication while in the ICU.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often a temporary emergency heart catheter, called a central venous catheter, stays in and causes problems in ICU patients. It may help doctors understand when to remove such catheters.
This study is looking at infections from central lines (special IVs in large veins) in ICU patients across China. It aims to understand how common these infections are and what factors contribute to them.
This research study looks at how often blood clots form around long-term catheters (thin tubes placed in veins) in hospitalized patients. The study uses ultrasound to check for clots and may help doctors understand and prevent this complication.
This study uses special CT scans (photon-counting CT) to look for blood clots related to central lines, both in patients who have passed away and in living patients. It aims to better understand and detect these clots.
This study looks at how often people with a blood infection from a PICC or midline catheter also get a blood clot in the vein of their arm. The goal is to learn more about this problem so doctors can better prevent and treat it.
This trial tests whether starting enoxaparin (a blood-thinner) within 24 hours after placing a specific type of central line can prevent dangerous clots. It may help reduce clot risk in people whose line is placed in the neck or thigh vein, while also tracking bleeding side effects.
Hear when a new Thrombosis, Venous trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.